Additional update: Results of ongoing investigator-initiated proof-of-concept trial in United Arab Emirates (UAE) demonstrate further reduction of total parenteral support (PS) (comprised of total parenteral nutrition and supplementary IV fluids) of approximately 37%

-Seasoned Executive with Proven Track Record in International Pump Launches to Accelerate Global Adoption of User Friendly, Affordable Patch Pumps

Fort Wayne Medical Education Program

Provides Flexibility to Pursue Long-Term Growth Strategy While Preserving Bitcoin Holdings and Strengthening the Company's Balance Sheet

Unbiased RespiClear Reviews and Complaints Expose Ingredients, Side Effects, Customer Experiences, Pricing, and Whether This Lung Health Supplement Is Legit

• Showcasing Disruptive Sublingual Drug Delivery Technology with Lead Program Targeting H2 2025 FDA Submission for Sublingual Aspirin

• Highlighting Key 2026 Milestones for Needle-Free Semaglutide (Diabetes, Weight Management) and a More-Rapid ED Medication

• Presentation and 1x1 Investor Meetings Scheduled Across the Two-Day Virtual Conference

Recognized for innovation in Biostatistics, Clinical Data Management, and Real-World Evidence, powered by AI-driven platforms

Brian Barnes, PhD and Nathan Taylor appointed CEO and President; Don Brown stepping down as CEO and will remain on the Board of Directors.

No. 1 among MSSP ACOs focused on long-term care and facility-based beneficiaries

From metabolic markers to hormone health, The Longevity Center offers personalized strategies rooted in data, not guesswork

US Med-Equip reports record demand as hospitals face flu & COVID surges, seek flexible, cost-controlling solutions without compromising patient care

- This acceptance follow's Dermata's U.S. issued patent covering its Spongilla technology combination as a method to topically treat acne -

- Dermata expects to launch a new once-weekly, Over-the-Counter (OTC) pharmaceutical acne kit, incorporating its Spongilla technology, in the middle of 2026 -

- Over 3.3 million people are diagnosed with acne in Australia -

Acquisition expands services across Alabama and strengthens company's presence in the Southeast

New Product Category Will Enable Added Flexibility to Support Commercial Launches of Cell and Gene Therapy

Copay Assistance From The Assistance Fund Now Available for Eligible People Living With B-Cell Lymphoma

Physician-Designed Formula With Salicylic Acid and Sodium Hypochlorite to Target Stubborn Skin Concerns

Secure, scalable, multi-cloud platform using federated learning aims to accelerate cancer discoveries and treatments

The Best FTM Top Surgeon is Dr. Javad Sajan at Allure Esthetic.

Prioritizes High-Value Approved Drugs in Multi-Billion-Dollar Markets to Accelerate Commercialization

Future Platform Expansion into CNS, Men's Health, and Anti-Nausea

Early Patient Feedback Points to Clearer Understanding of Results and Smoother Treatment Planning

Dentists can save big when they prescribe digital dentures at Glidewell

New 44-page Special Report details state readiness, equity strategies, and vendor alignment ahead of the November 5 CMS deadline

With the addition of two new Behavioral Health Advisors, Paradigm Treatment takes a key step toward getting more people the help they need for a bright and healthy future.

The two programs are being conducted under separate Single-Patient Investigational New Drug (sIND) applications in the United States

Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage - NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections

Dr. Nicole Schrader outlines the benefits of lower blepharoplasty with fat transfer, a procedure that blends tissue removal with natural volume restoration to correct puffiness, hollows, and shadows under the eyes.

Closing adds $5 million in marketable securities, strengthens financial position, and complements MIRA's advancing programs including Ketamir-2 and MIRA-55

With New York dispensaries projected to surpass $4.4 billion in annual sales by 2027, CBDL secures a transformative partnership poised to generate multi-million-dollar revenues and accelerate nationwide expansion.

NGS use is validated in 2025 American Urological Association guideline update, marking an important step towards more accurate and rapid urinary infection diagnostics.

Company to attend upcoming NewYorkBIO Innovation Summit on September 30, 2025, in New York City

The nonprofit organization calls on federal leaders to withhold funds from states restricting vaccine exemptions

Board-certified surgeons Dr. Gabriel Salloum and Dr. Roberto Mendez share insights into ear keloid treatment, emphasizing personalized care plans that combine surgical precision with advanced therapies for lasting results.

The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the skin using dissolvable Doxorubicin-containing Microneedle arrays (D-MNA) representing ~$2 billion in potential market opportunity

The Company plans to complete patient recruitment for SKNJCT-003 before the end of Q4 2025 and to request End-of-Phase 2 (EOP2) with the FDA in Q1 2026

755 practice managers reveal a good news/bad tech news reality as MGMA 2025 convenes in Orlando

For the eighth year, the Aesthetic Surgery Center is honored by the Naples Community's Choice Awards, with recognition spanning surgical excellence, spa care, and individual distinction for Dr. Anurag Agarwal.

Focused on Protecting Shareholder Value and Advancing Core Business